Oral diabetes drug semaglutide fights obesity in mice: A game-changer for human treatment?
The study reveals that oral semaglutide, a medication primarily used for type 2 diabetes, effectively reduces body weight and blood glucose levels in diet-induced obese mice. The findings suggest that this drug could be a promising treatment for obesity and offer a suitable animal model for future research.
Oral Semaglutide Human Protocols Doses Regulates Food Intake Body Weight Diet Induced Obese Image Credit
Source: news-medical.net